About Moderna, Inc. (MRNA)
Moderna, Inc. is a Biotechnology company operating in the Healthcare sector.
MRNA trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap stock .
Key Statistics
- Current Price
- $221.72
- Market Cap
- $88.52B
- 52-Week High
- $254.48
- 52-Week Low
- $22.28
- Sector
- Healthcare
- Industry
- Biotechnology
$1,000 Invested in Moderna, Inc. (MRNA)
How much would $1,000 invested in MRNA be worth today?
What would $1,000 invested in MRNA 1 year ago be worth today?
A $1,000 investment in Moderna, Inc. (MRNA) in 2025 would be worth $7,879 as of November 2026, representing a +687.9% total return.
What would $1,000 invested in MRNA 3 years ago be worth today?
A $1,000 investment in Moderna, Inc. (MRNA) in 2023 would be worth $2,918 as of November 2026, representing a +191.8% total return.
What would $1,000 invested in MRNA 5 years ago be worth today?
A $1,000 investment in Moderna, Inc. (MRNA) in 2021 would be worth $634 as of November 2026, representing a -36.6% total return.
What would $1,000 invested in MRNA at IPO be worth today?
A $1,000 investment in Moderna, Inc. (MRNA) at IPO would be worth $11,920 as of November 2026, representing a +1092.0% total return.
Monthly Returns Heatmap
Over the past 7+ years (94 months), Moderna, Inc. (MRNA) has averaged a monthly return of +5.91% with a median return of +1.85%. The stock had 51 positive months (54%) and 43 negative months (46%). The best month in MRNA's history was August 2026 with a +156.0% return, while the worst was August 2024 at -35.1%. Historically, November tends to be the strongest month (averaging +20.6%), and December the weakest (-3.3%).
MRNA's longest winning streak was 7 consecutive months of gains, while its longest losing streak was 8 consecutive months of losses. The best full year was 2020 with a cumulative return of +240.6%, and the worst was 2024 at -66.8%.
Annual Returns
Over 8 years of trading history, Moderna, Inc. (MRNA) has delivered an average annual return of +137.00% with a median return of -0.49%. The compound annual growth rate (CAGR) is +39.72%. The stock posted gains in 4 years (50%) and losses in 4 years (50%).
MRNA's best year was 2026 with a +651.85% gain, while the worst was 2024 at -58.19%. The longest streak of consecutive positive years was 3, and the longest losing streak was 4 years. MRNA achieved double-digit gains (10%+) in 4 years. It suffered double-digit losses in 4 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +651.85% | $29.49 | $221.72 |
| 2025 | -29.08% | $41.58 | $29.49 |
| 2024 | -58.19% | $99.45 | $41.58 |
| 2023 | -44.63% | $179.62 | $99.45 |
| 2022 | -29.28% | $253.98 | $179.62 |
| 2021 | +143.11% | $104.47 | $253.98 |
| 2020 | +434.10% | $19.56 | $104.47 |
| 2019 | +28.09% | $15.27 | $19.56 |
Frequently Asked Questions: MRNA
What sector is MRNA in? ▼
MRNA operates in the Healthcare sector, specifically in the Biotechnology industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has MRNA performed historically? ▼
Over 8 years of trading history, MRNA has posted gains in 4 years (50% of the time). The best year was 2026 with a +651.9% return. Past performance does not guarantee future results.
How can I invest in MRNA? ▼
You can invest in MRNA through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold MRNA.
Last updated: 11/1/2026